Isavuconazonium sulfate

Paul G. Auwaerter, M.D.

INDICATIONS

FDA

Invasive aspergillosis (IA)
Invasive mucormycosis (IM)

Granted orphan drug status for IA and IM by the FDA

NON-FDA APPROVED USES

Candida species (off-label)
Antifungal prophylaxis (off-label)

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.